Influence of time to first therapy (TTFT) variable on survival outcomes of neoadjuvant chemotherapy versus upfront surgery approach in resectable pancreatic ductal adenocarcinoma

被引：0
|
作者：
Sousa, Aryanna
Pena, Paola
Kwon, Steve
机构：
[1] Roger Williams Canc Outcomes Res & Equ RWCORE Ctr, Providence, RI USA
[2] Roger Williams Med Ctr, Providence, RI USA
[3] Rush Univ Med Ctr, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：720 / 720
页数：1
相关论文
共 50 条
  • [21] Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study
    Zou, Yiping
    Gao, Song
    Yu, Xin
    Zhou, Tianxing
    Xie, Yongjie
    Guo, Xiaofan
    An, Ran
    Wang, Xiuchao
    Zhao, Tiansuo
    Chang, Antao
    Gao, Chuntao
    Yu, Jun
    Hao, Jihui
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (06) : 1573 - 1583
  • [22] Survival outcomes of patients with resectable pancreatic cancer treated with upfront surgery versus neoadjuvant chemotherapy: A retrospective tertiary care center experience.
    Liu, Fang
    Mirsky, Matthew
    Wu, Sulin
    Fu, Pingfu
    Cao, Shufen
    Shanahan, John
    Kyasaram, Ravi Kumar
    Jain, Prantesh
    Hardacre, Jeffrey
    Ammori, John Brian
    Winter, Jordan Michael
    Bajor, David Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study
    Su, Yung-Yeh
    Chao, Ying-Jui
    Wang, Chih-Jung
    Liao, Ting-Kai
    Su, Ping-Jui
    Huang, Chien-Jui
    Chiang, Nai-Jung
    Yu, Yu-Ting
    Tsai, Hong-Ming
    Chen, Li-Tzong
    Shan, Yan-Shen
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (09) : 2614 - 2623
  • [24] Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials
    Ghanem, I.
    Lora, D.
    Herradon, N.
    de Velasco, G.
    Carretero-Gonzalez, A.
    Jimenez-Varas, M. A.
    de Parga, P. Vazquez
    Feliu, J.
    ESMO OPEN, 2022, 7 (03)
  • [25] The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma
    Ross, Sharona B.
    Popover, Jesse
    Sucandy, Iswanto
    Christodoulou, Maria
    Pattilachan, Tara M.
    Rosemurgy, Alexander S.
    AMERICAN SURGEON, 2024, 90 (11) : 3061 - 3073
  • [26] Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population
    Walpole, Imogen
    Lee, Belinda
    Shapiro, Jeremy
    Thomson, Benjamin
    Lipton, Lara
    Ananda, Sumitra
    Usatoff, Val
    Mclachlan, Sue-Ann
    Knowles, Brett
    Fox, Adrian
    Wong, Rachel
    Cooray, Prasad
    Burge, Matthew
    Clarke, Kate
    Pattison, Sharon
    Nikfarjam, Mehrdad
    Tebbutt, Niall
    Harris, Marion
    Nagrial, Adnan
    Zielinski, Rob
    Chee, Cheng Ean
    Gibbs, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 214 - 225
  • [27] Use and Outcomes from Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population
    Lee, Belinda
    Walpole, Imogen
    Shapiro, Julia
    Thomson, Benjamin
    Lipton, Lara
    Ananda, Sumitra
    Usatoff, Val
    Mclachlan, Sue-Anne
    Knowles, Brett
    Fox, Adrian
    Wong, Rachel
    Cooray, Prasad
    Burge, Matthew
    Clarke, Kate
    Pattison, Sharon
    Nikfarjam, Mehrdad
    Tebbutt, Niall
    Harris, Marion
    Nagrial, Adnan
    Zielinski, Rob
    Chee, Cheng Ean
    Gibbs, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 175 - 175
  • [28] Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
    da Costa, Wilson Luiz, Jr.
    Tran Cao, Hop S.
    Sheetz, Kyle H.
    Gu, Xiangjun
    Norton, Edward C.
    Massarweh, Nader N.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3186 - 3195
  • [29] Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
    Wilson Luiz da Costa
    Hop S. Tran Cao
    Kyle H. Sheetz
    Xiangjun Gu
    Edward C. Norton
    Nader N. Massarweh
    Annals of Surgical Oncology, 2021, 28 : 3186 - 3195
  • [30] Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis
    Bradley, Alison
    Van der Meer, Robert
    PLOS ONE, 2019, 14 (02):
12345